Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Alternatively spliced proline-rich cassettes link WNK1 to aldosterone action
Ankita Roy, … , Olivier Staub, Arohan R. Subramanya
Ankita Roy, … , Olivier Staub, Arohan R. Subramanya
Published August 4, 2015
Citation Information: J Clin Invest. 2015;125(9):3433-3448. https://doi.org/10.1172/JCI75245.
View: Text | PDF
Research Article Nephrology

Alternatively spliced proline-rich cassettes link WNK1 to aldosterone action

  • Text
  • PDF
Abstract

The thiazide-sensitive NaCl cotransporter (NCC) is important for renal salt handling and blood-pressure homeostasis. The canonical NCC-activating pathway consists of With-No-Lysine (WNK) kinases and their downstream effector kinases SPAK and OSR1, which phosphorylate NCC directly. The upstream mechanisms that connect physiological stimuli to this system remain obscure. Here, we have shown that aldosterone activates SPAK/OSR1 via WNK1. We identified 2 alternatively spliced exons embedded within a proline-rich region of WNK1 that contain PY motifs, which bind the E3 ubiquitin ligase NEDD4-2. PY motif–containing WNK1 isoforms were expressed in human kidney, and these isoforms were efficiently degraded by the ubiquitin proteasome system, an effect reversed by the aldosterone-induced kinase SGK1. In gene-edited cells, WNK1 deficiency negated regulatory effects of NEDD4-2 and SGK1 on NCC, suggesting that WNK1 mediates aldosterone-dependent activity of the WNK/SPAK/OSR1 pathway. Aldosterone infusion increased proline-rich WNK1 isoform abundance in WT mice but did not alter WNK1 abundance in hypertensive Nedd4-2 KO mice, which exhibit high baseline WNK1 and SPAK/OSR1 activity toward NCC. Conversely, hypotensive Sgk1 KO mice exhibited low WNK1 expression and activity. Together, our findings indicate that the proline-rich exons are modular cassettes that convert WNK1 into a NEDD4-2 substrate, thereby linking aldosterone and other NEDD4-2–suppressing antinatriuretic hormones to NCC phosphorylation status.

Authors

Ankita Roy, Lama Al-Qusairi, Bridget F. Donnelly, Caroline Ronzaud, Allison L. Marciszyn, Fan Gong, Y.P. Christy Chang, Michael B. Butterworth, Núria M. Pastor-Soler, Kenneth R. Hallows, Olivier Staub, Arohan R. Subramanya

×

Figure 7

WNK1 is necessary for NEDD4-2 and SGK1 to modulate NCC abundance and phosphorylation in HEK-293 cells.

Options: View larger image (or click on image) Download as PowerPoint
WNK1 is necessary for NEDD4-2 and SGK1 to modulate NCC abundance and pho...
(A) WNK1 KO HEK-293T cells and unedited controls were transfected with NCC (1 μg), SGK1-S422D (1 μg), and either WT or phosphorylation-resistant (PR) NEDD4-2 (1 μg). Thirty-six hours after transfection, the cells were lysed and subjected to immunoblotting with the indicated antibodies. (B) Quantification of total NCC, phosphorylated NCC, and phosphorylated SPAK/OSR1 signal in A. n = 4; P values as indicated by 1-Way ANOVA Bonferroni multiple-comparisons post hoc test. (C) Proposed model of the effects of WNK1 deletion on NEDD4-2/SGK1 regulation of NCC in HEK-293T cells. In unedited cells, WT NEDD4-2 interacts with L-WNK1. This interaction can be disrupted by SGK1 phosphorylation at previously defined major and minor sites, increasing L-WNK1 abundance, SPAK/OSR1 phosphorylation, and NCC activation. In WNK1 KO cells, NEDD4-2 and SGK1 cannot alter NCC phosphorylation status. Other regulators, possibly WNK complexes that are less NEDD4-2 sensitive, maintain NCC activity through compensation.

Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts